Literature DB >> 23734614

Cognitive flexibility among individuals with Down syndrome: assessing the influence of verbal and nonverbal abilities.

Colin Campbell1, Oriane Landry, Natalie Russo, Heidi Flores, Sophie Jacques, Jacob A Burack.   

Abstract

The influences of verbal mental age (VMA) and performance mental age (PMA) on cognitive flexibility were examined among a group of participants with Down syndrome (DS), in order to disentangle the relative contributions of each. The impaired cognitive flexibility typically observed among individuals with DS in combination with uneven VMA and PMA development suggests an opportunity to further understand the developmental relationship between VMA, PMA, and cognitive flexibility. We examined the performance of 22 participants with DS on the Flexible Item Selection Task (FIST), used for measuring cognitive flexibility among preschoolers. Partial correlations revealed that only VMA was related to the FIST after controlling for PMA, highlighting the role of verbal abilities in the development of cognitive flexibility.

Entities:  

Mesh:

Year:  2013        PMID: 23734614     DOI: 10.1352/1944-7558-118.3.193

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  10 in total

1.  Choices, challenges, and constraints: a pragmatic examination of the limits of mental age matching in empirical research.

Authors:  N Russo; E A Kaplan-Kahn; J Wilson; A Criss; J A Burack
Journal:  Dev Psychopathol       Date:  2021-05

2.  Reliability of Informant-Report Measures of Executive Functioning in Children With Down Syndrome.

Authors:  Anna J Esbensen; Emily K Hoffman; Rebecca Shaffer; Elizabeth Chen; Lina Patel; Lisa Jacola
Journal:  Am J Intellect Dev Disabil       Date:  2019-05

3.  Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome.

Authors:  J Luis Olmos-Serrano; William A Tyler; Howard J Cabral; Tarik F Haydar
Journal:  Exp Neurol       Date:  2016-02-24       Impact factor: 5.330

4.  Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.

Authors:  Joseph W Goodliffe; Jose Luis Olmos-Serrano; Nadine M Aziz; Jeroen L A Pennings; Faycal Guedj; Diana W Bianchi; Tarik F Haydar
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

5.  The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Authors:  Md Mahiuddin Ahmed; Athena Ching-Jung Wang; Mihret Elos; Heidi J Chial; Stefan Sillau; D Adriana Solano; Christina Coughlan; Leila Aghili; Paige Anton; Neil Markham; Vanesa Adame; Katheleen J Gardiner; Timothy D Boyd; Huntington Potter
Journal:  Neurobiol Dis       Date:  2022-03-18       Impact factor: 7.046

6.  Impact of sleep on executive functioning in school-age children with Down syndrome.

Authors:  A J Esbensen; E K Hoffman
Journal:  J Intellect Disabil Res       Date:  2018-04-25

7.  Verbal and nonverbal predictors of executive function in early childhood.

Authors:  Rebecca L Stephens; Benjamin Langworthy; Sarah J Short; Barbara D Goldman; Jessica B Girault; Jason P Fine; J Steven Reznick; John H Gilmore
Journal:  J Cogn Dev       Date:  2018-02-27

8.  Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome.

Authors:  Damien Marechal; Patricia Lopes Pereira; Arnaud Duchon; Yann Herault
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Motor, linguistic, personal and social aspects of children with Down syndrome.

Authors:  Amanda Tragueta Ferreira-Vasques; Dionísia Aparecida Cusin Lamônica
Journal:  J Appl Oral Sci       Date:  2015 Jul-Aug       Impact factor: 2.698

10.  Different abilities needed at home and school: The relation between executive function and adaptive behaviour in adolescents with Down syndrome.

Authors:  Camila Sabat; Paulina Arango; Marc J Tassé; Marcela Tenorio
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.